CD8A and neoplasm: It has been demonstrated first in colorectal cancer (CRC) that CD3+ and CD8+ lymphocytes are spatially differentially distributed between the tumor center (TC) and the ITF and that the density and pattern of these immune infiltrates were associated with CRC patient outcome [43].